JnJ to acquire Ambrx Biopharma for USD 2 billion Ruchika Sharma11 Jan 2024 12:30 PM ISTNew Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement to acquire Ambrx Biopharma, Inc., or Ambrx, a...
Judge certifies JnJ shareholder class action over talc disclosures Ruchika Sharma30 Dec 2023 1:30 PM ISTNew York: A federal judge said Johnson & Johnson shareholders may pursue as a class action their lawsuit accusing the company of fraudulently...
Janssen seeks EMA marketing nod for Lazertinib plus Rybrevant for EGFR-Mutated Non Small Cell Lung Cancer Ruchika Sharma25 Dec 2023 3:30 PM ISTBelgium: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a marketing authorisation application...
JnJ seeks USFDA nod for Rybrevant plus Lazertinib for EGFR-Mutated Non-Small Cell Lung Cancer Ruchika Sharma24 Dec 2023 12:30 PM ISTRaritan: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
JnJ gets USFDA breakthrough therapy designation for TAR 200 for bladder cancer treatment Ruchika Sharma5 Dec 2023 11:27 AM ISTTAR-200 is a novel investigational targeted releasing system designed to provide sustained local release of gemcitabine into the bladder.
JnJ appoints Eugene A Woods to its Board of Directors Ruchika Sharma3 Dec 2023 12:45 PM ISTNew Brunswick: Johnson & Johnson has announced that Eugene A. Woods, MBA, MHA, Chief Executive Officer of Advocate Health, has been appointed...
Johnson & Johnson MedTech buys Laminar for USD 400 million Ruchika Sharma3 Dec 2023 12:30 PM ISTNew Brunswick: Johnson & Johnson MedTech has announced the completion of the acquisition of Laminar, Inc., a privately-held medical device...
Janssen seeks USFDA nod for Rybrevant plus chemotherapy for patients with EGFR-Mutated Non-Small Cell Lung Cancer who progressed on or after Osimertinib Ruchika Sharma23 Nov 2023 2:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental Biologics License ...
Sanofi completes closing for potential vaccine against extraintestinal pathogenic E.coli Ruchika Sharma12 Nov 2023 5:00 PM ISTParis: Sanofi has announced the completion of closing for its collaborative agreement with Janssen Pharmaceuticals, Inc., a Johnson & Johnson...
Johnson and Johnson faces 18 talc cancer trials, prompting it again to consider bankruptcy Roshni Dhar30 Oct 2023 2:25 PM ISTJohnson & Johnson faces at least 18 jury trials over the next year tied to claims of tainted talc in its iconic baby powder, prompting the company...
JnJ faces 18 talc cancer trials, prompting it again to consider bankruptcy Ruchika Sharma27 Oct 2023 5:25 PM ISTJohnson & Johnson faces at least 18 jury trials over the next year tied to claims of tainted talc in its iconic baby powder, prompting the company...
JnJ names Tim Schmid as Executive Vice President, Worldwide Chairman of MedTech Ruchika Sharma25 Oct 2023 1:30 PM ISTNew Brunswick: Johnson & Johnson has announced that Ashley McEvoy, Executive Vice President, Worldwide Chairman of MedTech, informed the...
